Loading…
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors
AbstractBackground and AimHFE-related Hemochromatosis (HH) is characterized by marked phenotype heterogeneity, probably due to the combined action of acquired and genetic factors. Among them, GNPAT rs11558492 was proposed as genetic modifier of iron status, but results are still controversial. To sh...
Saved in:
Published in: | Annals of hepatology 2017-05, Vol.16 (3), p.451-456 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63 |
---|---|
cites | cdi_FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63 |
container_end_page | 456 |
container_issue | 3 |
container_start_page | 451 |
container_title | Annals of hepatology |
container_volume | 16 |
creator | Greni, Federico Valenti, Luca Mariani, Raffaella Pelloni, Irene Rametta, Raffaela Busti, Fabiana Ravasi, Giulia Girelli, Domenico Fargion, Silvia Galimberti, Stefania Piperno, Alberto Pelucchi, Sara |
description | AbstractBackground and AimHFE-related Hemochromatosis (HH) is characterized by marked phenotype heterogeneity, probably due to the combined action of acquired and genetic factors. Among them, GNPAT rs11558492 was proposed as genetic modifier of iron status, but results are still controversial. To shed light on these discrepancies, we genotyped 298 Italian p.C282Y homozygotes and 169 healthy controls. Material and MethodsAllele and genotype frequencies were analysed and compared with those reported in Exome Variant Server (EVS). To explore the role of rs11558492 as a potential modifier of iron status, serum ferritin (SF), liver iron concentration (LIC) and iron removed (IR) were studied according to allele and genotype frequencies. In addition, the effect of the SNP on liver fibrosis was examined comparing patients with absent/mild-moderate fibrosis to those with severe fibrosis-cirrho-sis. ResultsGNPAT rs11558492 minor allele (G) frequency (MAF) was 20.3% in HFE-HH, 17.2% in controls and 20.6% in EVS database. Genotype frequencies were 64% and 69.2% (AA), 31.2% and 27.2% (AG), 4.8% and 3.6% (GG) in HFE-HH and controls, respectively. No significant differences were found comparing genotype and allele frequencies even selecting subgroups of only-males with extreme phenotypes and low alcohol intake. SF, IR and LIC levels did not significantly differ according to rs11558492 genotypes. Also, MAF did not differ between patients with absent/mild fibrosis and severe fibrosis/cirrhosis. ConclusionsOur findings indicate that GNPAT rs11558492 is not a major modifier of iron status and is not associated with liver fibrosis in HFE-HH patients. |
doi_str_mv | 10.5604/01.3001.0009.8601 |
format | article |
fullrecord | <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_22a550f4830b4e8abbb5e878a0146285</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1665268119304193</els_id><doaj_id>oai_doaj_org_article_22a550f4830b4e8abbb5e878a0146285</doaj_id><sourcerecordid>28425416</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63</originalsourceid><addsrcrecordid>eNo9kc9uFDEMh-cAoqXwAFxQXmAXO_8mwwGptNCu1EKllnPkySSQZXZSJbNI-_ZkutCLLVn2J_n3Nc07hLXSID8ArgXUAgDd2mjAF80paq1WXBs8aV6XsgWQQiF_1ZxwI7mSqE-bcvXt7vyB5YKolJEdZ7GwKc2M2C1tU2a3aYgh-sxSYJucJnY_07wvH2vfD4en6UxjpIld-11yv3La0ZxKpdzRHP00F0bTwD6PKQ3sMk0plzfNy0Bj8W__9bPmx9cvDxfXq5vvV5uL85uV422LKzQDl0o7iYEHlA54C6JteyXAmWA60QUhoAeujAA5KBeGtm0NahImcNLirNkcuUOirX3McUf5YBNF-zRI-aelPEc3ess5KQVBVlIvvaG-75U3rSFAqblRlYVHlsuplOzDMw_BLgIsoF0E2EWAXQTUm_fHm8d9v_PD88X_9OvCp-OCryn8qSFbN8YpOhp_-4Mv27TPUw3Ioi3cgr1ffC46sasP1yL-ApCzk3c</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors</title><source>ScienceDirect Journals</source><creator>Greni, Federico ; Valenti, Luca ; Mariani, Raffaella ; Pelloni, Irene ; Rametta, Raffaela ; Busti, Fabiana ; Ravasi, Giulia ; Girelli, Domenico ; Fargion, Silvia ; Galimberti, Stefania ; Piperno, Alberto ; Pelucchi, Sara</creator><creatorcontrib>Greni, Federico ; Valenti, Luca ; Mariani, Raffaella ; Pelloni, Irene ; Rametta, Raffaela ; Busti, Fabiana ; Ravasi, Giulia ; Girelli, Domenico ; Fargion, Silvia ; Galimberti, Stefania ; Piperno, Alberto ; Pelucchi, Sara</creatorcontrib><description>AbstractBackground and AimHFE-related Hemochromatosis (HH) is characterized by marked phenotype heterogeneity, probably due to the combined action of acquired and genetic factors. Among them, GNPAT rs11558492 was proposed as genetic modifier of iron status, but results are still controversial. To shed light on these discrepancies, we genotyped 298 Italian p.C282Y homozygotes and 169 healthy controls. Material and MethodsAllele and genotype frequencies were analysed and compared with those reported in Exome Variant Server (EVS). To explore the role of rs11558492 as a potential modifier of iron status, serum ferritin (SF), liver iron concentration (LIC) and iron removed (IR) were studied according to allele and genotype frequencies. In addition, the effect of the SNP on liver fibrosis was examined comparing patients with absent/mild-moderate fibrosis to those with severe fibrosis-cirrho-sis. ResultsGNPAT rs11558492 minor allele (G) frequency (MAF) was 20.3% in HFE-HH, 17.2% in controls and 20.6% in EVS database. Genotype frequencies were 64% and 69.2% (AA), 31.2% and 27.2% (AG), 4.8% and 3.6% (GG) in HFE-HH and controls, respectively. No significant differences were found comparing genotype and allele frequencies even selecting subgroups of only-males with extreme phenotypes and low alcohol intake. SF, IR and LIC levels did not significantly differ according to rs11558492 genotypes. Also, MAF did not differ between patients with absent/mild fibrosis and severe fibrosis/cirrhosis. ConclusionsOur findings indicate that GNPAT rs11558492 is not a major modifier of iron status and is not associated with liver fibrosis in HFE-HH patients.</description><identifier>ISSN: 1665-2681</identifier><identifier>DOI: 10.5604/01.3001.0009.8601</identifier><identifier>PMID: 28425416</identifier><language>eng</language><publisher>Mexico: Elsevier</publisher><subject>Acyltransferases - genetics ; Adult ; Biomarkers - blood ; Blood Donors ; Case-Control Studies ; Female ; Ferritins - blood ; Gastroenterology and Hepatology ; Gene Frequency ; Genetic Association Studies ; Genetic Predisposition to Disease ; Glyceronephosphate O-acyltransferase ; Hemochromatosis - blood ; Hemochromatosis - diagnosis ; Hemochromatosis - enzymology ; Hemochromatosis - genetics ; Hemochromatosis Protein - genetics ; Hereditary hemochromatosis ; Heterozygote ; Homozygote ; Humans ; Iron - blood ; Iron overload ; Italy ; Liver - metabolism ; Liver Cirrhosis - blood ; Liver Cirrhosis - diagnosis ; Liver Cirrhosis - enzymology ; Liver Cirrhosis - genetics ; Male ; Middle Aged ; Phenotype ; Polymorphism ; Polymorphism, Single Nucleotide ; Risk Factors ; Serum ferritin</subject><ispartof>Annals of hepatology, 2017-05, Vol.16 (3), p.451-456</ispartof><rights>Fundación Clínica Médica Sur, A.C.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63</citedby><cites>FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28425416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Greni, Federico</creatorcontrib><creatorcontrib>Valenti, Luca</creatorcontrib><creatorcontrib>Mariani, Raffaella</creatorcontrib><creatorcontrib>Pelloni, Irene</creatorcontrib><creatorcontrib>Rametta, Raffaela</creatorcontrib><creatorcontrib>Busti, Fabiana</creatorcontrib><creatorcontrib>Ravasi, Giulia</creatorcontrib><creatorcontrib>Girelli, Domenico</creatorcontrib><creatorcontrib>Fargion, Silvia</creatorcontrib><creatorcontrib>Galimberti, Stefania</creatorcontrib><creatorcontrib>Piperno, Alberto</creatorcontrib><creatorcontrib>Pelucchi, Sara</creatorcontrib><title>GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors</title><title>Annals of hepatology</title><addtitle>Ann Hepatol</addtitle><description>AbstractBackground and AimHFE-related Hemochromatosis (HH) is characterized by marked phenotype heterogeneity, probably due to the combined action of acquired and genetic factors. Among them, GNPAT rs11558492 was proposed as genetic modifier of iron status, but results are still controversial. To shed light on these discrepancies, we genotyped 298 Italian p.C282Y homozygotes and 169 healthy controls. Material and MethodsAllele and genotype frequencies were analysed and compared with those reported in Exome Variant Server (EVS). To explore the role of rs11558492 as a potential modifier of iron status, serum ferritin (SF), liver iron concentration (LIC) and iron removed (IR) were studied according to allele and genotype frequencies. In addition, the effect of the SNP on liver fibrosis was examined comparing patients with absent/mild-moderate fibrosis to those with severe fibrosis-cirrho-sis. ResultsGNPAT rs11558492 minor allele (G) frequency (MAF) was 20.3% in HFE-HH, 17.2% in controls and 20.6% in EVS database. Genotype frequencies were 64% and 69.2% (AA), 31.2% and 27.2% (AG), 4.8% and 3.6% (GG) in HFE-HH and controls, respectively. No significant differences were found comparing genotype and allele frequencies even selecting subgroups of only-males with extreme phenotypes and low alcohol intake. SF, IR and LIC levels did not significantly differ according to rs11558492 genotypes. Also, MAF did not differ between patients with absent/mild fibrosis and severe fibrosis/cirrhosis. ConclusionsOur findings indicate that GNPAT rs11558492 is not a major modifier of iron status and is not associated with liver fibrosis in HFE-HH patients.</description><subject>Acyltransferases - genetics</subject><subject>Adult</subject><subject>Biomarkers - blood</subject><subject>Blood Donors</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Ferritins - blood</subject><subject>Gastroenterology and Hepatology</subject><subject>Gene Frequency</subject><subject>Genetic Association Studies</subject><subject>Genetic Predisposition to Disease</subject><subject>Glyceronephosphate O-acyltransferase</subject><subject>Hemochromatosis - blood</subject><subject>Hemochromatosis - diagnosis</subject><subject>Hemochromatosis - enzymology</subject><subject>Hemochromatosis - genetics</subject><subject>Hemochromatosis Protein - genetics</subject><subject>Hereditary hemochromatosis</subject><subject>Heterozygote</subject><subject>Homozygote</subject><subject>Humans</subject><subject>Iron - blood</subject><subject>Iron overload</subject><subject>Italy</subject><subject>Liver - metabolism</subject><subject>Liver Cirrhosis - blood</subject><subject>Liver Cirrhosis - diagnosis</subject><subject>Liver Cirrhosis - enzymology</subject><subject>Liver Cirrhosis - genetics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Phenotype</subject><subject>Polymorphism</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Risk Factors</subject><subject>Serum ferritin</subject><issn>1665-2681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9kc9uFDEMh-cAoqXwAFxQXmAXO_8mwwGptNCu1EKllnPkySSQZXZSJbNI-_ZkutCLLVn2J_n3Nc07hLXSID8ArgXUAgDd2mjAF80paq1WXBs8aV6XsgWQQiF_1ZxwI7mSqE-bcvXt7vyB5YKolJEdZ7GwKc2M2C1tU2a3aYgh-sxSYJucJnY_07wvH2vfD4en6UxjpIld-11yv3La0ZxKpdzRHP00F0bTwD6PKQ3sMk0plzfNy0Bj8W__9bPmx9cvDxfXq5vvV5uL85uV422LKzQDl0o7iYEHlA54C6JteyXAmWA60QUhoAeujAA5KBeGtm0NahImcNLirNkcuUOirX3McUf5YBNF-zRI-aelPEc3ess5KQVBVlIvvaG-75U3rSFAqblRlYVHlsuplOzDMw_BLgIsoF0E2EWAXQTUm_fHm8d9v_PD88X_9OvCp-OCryn8qSFbN8YpOhp_-4Mv27TPUw3Ioi3cgr1ffC46sasP1yL-ApCzk3c</recordid><startdate>201705</startdate><enddate>201705</enddate><creator>Greni, Federico</creator><creator>Valenti, Luca</creator><creator>Mariani, Raffaella</creator><creator>Pelloni, Irene</creator><creator>Rametta, Raffaela</creator><creator>Busti, Fabiana</creator><creator>Ravasi, Giulia</creator><creator>Girelli, Domenico</creator><creator>Fargion, Silvia</creator><creator>Galimberti, Stefania</creator><creator>Piperno, Alberto</creator><creator>Pelucchi, Sara</creator><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>201705</creationdate><title>GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors</title><author>Greni, Federico ; Valenti, Luca ; Mariani, Raffaella ; Pelloni, Irene ; Rametta, Raffaela ; Busti, Fabiana ; Ravasi, Giulia ; Girelli, Domenico ; Fargion, Silvia ; Galimberti, Stefania ; Piperno, Alberto ; Pelucchi, Sara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acyltransferases - genetics</topic><topic>Adult</topic><topic>Biomarkers - blood</topic><topic>Blood Donors</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Ferritins - blood</topic><topic>Gastroenterology and Hepatology</topic><topic>Gene Frequency</topic><topic>Genetic Association Studies</topic><topic>Genetic Predisposition to Disease</topic><topic>Glyceronephosphate O-acyltransferase</topic><topic>Hemochromatosis - blood</topic><topic>Hemochromatosis - diagnosis</topic><topic>Hemochromatosis - enzymology</topic><topic>Hemochromatosis - genetics</topic><topic>Hemochromatosis Protein - genetics</topic><topic>Hereditary hemochromatosis</topic><topic>Heterozygote</topic><topic>Homozygote</topic><topic>Humans</topic><topic>Iron - blood</topic><topic>Iron overload</topic><topic>Italy</topic><topic>Liver - metabolism</topic><topic>Liver Cirrhosis - blood</topic><topic>Liver Cirrhosis - diagnosis</topic><topic>Liver Cirrhosis - enzymology</topic><topic>Liver Cirrhosis - genetics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Phenotype</topic><topic>Polymorphism</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Risk Factors</topic><topic>Serum ferritin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Greni, Federico</creatorcontrib><creatorcontrib>Valenti, Luca</creatorcontrib><creatorcontrib>Mariani, Raffaella</creatorcontrib><creatorcontrib>Pelloni, Irene</creatorcontrib><creatorcontrib>Rametta, Raffaela</creatorcontrib><creatorcontrib>Busti, Fabiana</creatorcontrib><creatorcontrib>Ravasi, Giulia</creatorcontrib><creatorcontrib>Girelli, Domenico</creatorcontrib><creatorcontrib>Fargion, Silvia</creatorcontrib><creatorcontrib>Galimberti, Stefania</creatorcontrib><creatorcontrib>Piperno, Alberto</creatorcontrib><creatorcontrib>Pelucchi, Sara</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Greni, Federico</au><au>Valenti, Luca</au><au>Mariani, Raffaella</au><au>Pelloni, Irene</au><au>Rametta, Raffaela</au><au>Busti, Fabiana</au><au>Ravasi, Giulia</au><au>Girelli, Domenico</au><au>Fargion, Silvia</au><au>Galimberti, Stefania</au><au>Piperno, Alberto</au><au>Pelucchi, Sara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors</atitle><jtitle>Annals of hepatology</jtitle><addtitle>Ann Hepatol</addtitle><date>2017-05</date><risdate>2017</risdate><volume>16</volume><issue>3</issue><spage>451</spage><epage>456</epage><pages>451-456</pages><issn>1665-2681</issn><abstract>AbstractBackground and AimHFE-related Hemochromatosis (HH) is characterized by marked phenotype heterogeneity, probably due to the combined action of acquired and genetic factors. Among them, GNPAT rs11558492 was proposed as genetic modifier of iron status, but results are still controversial. To shed light on these discrepancies, we genotyped 298 Italian p.C282Y homozygotes and 169 healthy controls. Material and MethodsAllele and genotype frequencies were analysed and compared with those reported in Exome Variant Server (EVS). To explore the role of rs11558492 as a potential modifier of iron status, serum ferritin (SF), liver iron concentration (LIC) and iron removed (IR) were studied according to allele and genotype frequencies. In addition, the effect of the SNP on liver fibrosis was examined comparing patients with absent/mild-moderate fibrosis to those with severe fibrosis-cirrho-sis. ResultsGNPAT rs11558492 minor allele (G) frequency (MAF) was 20.3% in HFE-HH, 17.2% in controls and 20.6% in EVS database. Genotype frequencies were 64% and 69.2% (AA), 31.2% and 27.2% (AG), 4.8% and 3.6% (GG) in HFE-HH and controls, respectively. No significant differences were found comparing genotype and allele frequencies even selecting subgroups of only-males with extreme phenotypes and low alcohol intake. SF, IR and LIC levels did not significantly differ according to rs11558492 genotypes. Also, MAF did not differ between patients with absent/mild fibrosis and severe fibrosis/cirrhosis. ConclusionsOur findings indicate that GNPAT rs11558492 is not a major modifier of iron status and is not associated with liver fibrosis in HFE-HH patients.</abstract><cop>Mexico</cop><pub>Elsevier</pub><pmid>28425416</pmid><doi>10.5604/01.3001.0009.8601</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1665-2681 |
ispartof | Annals of hepatology, 2017-05, Vol.16 (3), p.451-456 |
issn | 1665-2681 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_22a550f4830b4e8abbb5e878a0146285 |
source | ScienceDirect Journals |
subjects | Acyltransferases - genetics Adult Biomarkers - blood Blood Donors Case-Control Studies Female Ferritins - blood Gastroenterology and Hepatology Gene Frequency Genetic Association Studies Genetic Predisposition to Disease Glyceronephosphate O-acyltransferase Hemochromatosis - blood Hemochromatosis - diagnosis Hemochromatosis - enzymology Hemochromatosis - genetics Hemochromatosis Protein - genetics Hereditary hemochromatosis Heterozygote Homozygote Humans Iron - blood Iron overload Italy Liver - metabolism Liver Cirrhosis - blood Liver Cirrhosis - diagnosis Liver Cirrhosis - enzymology Liver Cirrhosis - genetics Male Middle Aged Phenotype Polymorphism Polymorphism, Single Nucleotide Risk Factors Serum ferritin |
title | GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T06%3A01%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GNPAT%20rs11558492%20is%20not%20a%20Major%20Modifier%20of%20Iron%20Status:%20Study%20of%20Italian%20Hemochromatosis%20Patients%20and%20Blood%20Donors&rft.jtitle=Annals%20of%20hepatology&rft.au=Greni,%20Federico&rft.date=2017-05&rft.volume=16&rft.issue=3&rft.spage=451&rft.epage=456&rft.pages=451-456&rft.issn=1665-2681&rft_id=info:doi/10.5604/01.3001.0009.8601&rft_dat=%3Cpubmed_doaj_%3E28425416%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/28425416&rfr_iscdi=true |